巨大平滑肌瘤子宫患者中的附件囊性淋巴管瘤:盆腔MRI上并不少见的发现
这项回顾性观察研究利用10年MRI数据库分析85例子宫增大伴轮廓扭曲的平滑肌瘤患者,发现附件囊性淋巴管瘤(ACL)见于17/85(20%)。ACL与肌瘤数目更多、最大肌瘤最长径更大及子宫体积更大显著相关,最大肌瘤最长径9.1 cm预测ACL的AUC为0.83。
要点
- 子宫增大伴多发或巨大平滑肌瘤的患者中,盆腔MRI发现附件囊性淋巴管瘤的比例可达20%。
- 最大肌瘤位于宫底时ACL出现更频繁(33.3%),肌瘤数目、最大径及子宫体积均与ACL显著相关。
- 最大肌瘤最长径9.1 cm、子宫体积311 cm3、肌瘤数目5个为预测ACL的ROC最佳截断值。
核心结论
- ACL的存在与肌瘤数目、最大肌瘤最长径及子宫体积显著相关;作者指出需前瞻性评估这些结果以探究其临床意义。
研究设计与样本
- 回顾性观察研究,由两名专家放射科医生使用2008-2018年10年MRI数据库,纳入85例因单发(n=31)或多发(n=54)肌瘤导致子宫轮廓扭曲和子宫增大的患者(平均年龄45.5岁±10.9)。
关键影像表现/征象
- ACL表现为附件区囊性病变,单侧9例、双侧8例,共17/85(20%)患者记录到ACL。
- ACL在最大肌瘤位于宫底时更常见(33.3%)。
- ACL诊断基于典型影像学特征(n=14)和术中/组织学发现(n=3)。
诊断标准与关键数值
- 肌瘤数目预测ACL的最佳截断值为5个,敏感度53.8%、特异度84%(AUC=0.65,95%CI 0.51-0.83,p=0.049)。
- 最大肌瘤最长径预测ACL的最佳截断值为9.1 cm,敏感度76.5%、特异度77.9%(AUC=0.83,95%CI 0.73-0.94,p<0.001)。
- 子宫体积预测ACL的最佳截断值为311 cm3,敏感度71%、特异度75%(AUC=0.79,95%CI 0.66-0.92,p<0.001)。
临床应用与阅片要点
- 在子宫增大伴多发或巨大平滑肌瘤的患者中阅片时,应注意附件区囊性病变,ACL可见于20%的此类患者。
- 最大肌瘤位于宫底、肌瘤数目≥5个、最大肌瘤最长径≥9.1 cm或子宫体积≥311 cm3时,ACL的可能性增加。
局限性
- 原文为回顾性观察研究。
- 作者指出需前瞻性评估这些结果以探究其临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate any association between the presence of an adnexal cystic lymphangioma (ACL) and an enlarged leiomyomatous uterus.
METHODS: A retrospective observational study was conducted by two expert radiologists using a 10-year MRI database (2008-2018); 85 patients (mean age: 45.5 years ± 10.9) were considered eligible due to the presence of a single (n = 31) or multiple (n = 54) leiomyomas causing distortion of the uterine contour and uterine enlargement. The association of specific leiomyoma features (longest diameter (Dmax), location, number) and uterine volume with the presence of ACL was statistically tested. Diagnosis of ACL was based on typical imaging features (n = 14) and intraoperative/histological findings (n = 3).
RESULTS: ACL (unilateral = 9, bilateral = 8) was recorded in 17/85 (20%) of patients; it was more frequently observed when the largest leiomyoma was located in the uterine fundus (33.3%). Patients with ACL had significantly more leiomyomas (median: 5 vs. 2, p = 0.043), greater Dmax of largest leiomyoma (median: 13.3 vs. 7.2 cm, p < 0.001), and larger uterine volumes (median: 676.7 vs. 223.1 cm3, p < 0.001) compared to patients without ACL. ROC curve analysis for a number of leiomyomas showed that the optimal cut-off for the prediction of ACL was the presence of 5 leiomyomas with 53.8% sensitivity and 84% specificity (AUC = 0.65, 95% CI 0.51-0.83, p = 0.049), Dmax of largest leiomyoma 9.1 cm with 76.5% sensitivity and 77.9% specificity (AUC = 0.83, 95% CI 0.73-0.94, p < 0.001), and uterine volume 311 cm3 with 71% sensitivity and 75% specificity (AUC = 0.79, 95% CI 0.66-0.92, p < 0.001).
CONCLUSIONS: The presence of ACL is significantly associated with number of leiomyomas, Dmax of largest leiomyoma, and uterine volume; prospective evaluation of our results is needed to investigate its clinical significance.
引用
- Bourgioti C, Chatoupis K, Tzavara C, et al. Αdnexal cystic lymphangiomas in patients with massive leiomyomatous uterus: a not so uncommon finding on pelvic MRI. Abdom Radiol (NY). 2020. PMID: 31218386. doi:10.1007/s00261-019-02106-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。